Skip to main content
Clinical Trials/NCT05053256
NCT05053256
Unknown
Not Applicable

The Relationship Between Heart Function and Metabolism in Heart Failure With Preserved Ejection Fraction Patients

Chongqing Medical University1 site in 1 country400 target enrollmentOctober 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure With Preserved Ejection Fraction
Sponsor
Chongqing Medical University
Enrollment
400
Locations
1
Primary Endpoint
Body fat content
Last Updated
3 years ago

Overview

Brief Summary

HFpEF has gradually become the most common form of heart failure. Studies have found that metabolic abnormalities and chronic inflammation ultimately lead to HFpEF by promoting heart remodeling. However, there are few relevant studies and the mechanism is still unclear.

Detailed Description

However, heart failure with preserved ejection fraction is difficult to diagnose and treat due to its unknown pathogenesis and poor prognosis. Ventricular diastolic dysfunction and retention of left ventricular ejection fraction are important pathological features of Heart failure with preserved ejection fraction. Currently, it is widely believed to be a clinical syndrome associated with old age, women, obesity, diabetes, hypertension, atrial fibrillation, coronary heart disease, atherosclerosis, etc. However, the specific mechanism of heart failure with preserved ejection fraction caused by the above-mentioned complications is unknown. In conclusion, the investigators intend to explore the pathogenesis of heart failure with preserved ejection fraction by observing the changes of heart and body metabolism in patients with heart failure with preserved ejection fraction, and provide a basis for the diagnosis and treatment.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
September 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chongqing Medical University
Responsible Party
Principal Investigator
Principal Investigator

Dongying Zhang

Clinical Professor

Chongqing Medical University

Eligibility Criteria

Inclusion Criteria

  • Adult aged ≥ 18 years old
  • Patients diagnosed with HFpEF;
  • Diagnostic criteria including:
  • LVEF 50% or higher;
  • BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL;
  • Presence of symptoms and/or signs of heart failure;
  • At least one additional criteria: relevant structure heart disease or diastolic dysfunction

Exclusion Criteria

  • Severe liver failure;
  • Other causes of shortness of breath, such as severe pulmonary disease or severe ● chronic obstructive pulmonary disease;
  • Primary pulmonary hypertension.
  • Severe left valvular heart disease.
  • Long-term bedridden or unable to move autonomously
  • Age \< 18

Outcomes

Primary Outcomes

Body fat content

Time Frame: On admission

The body fat content of HFpEF patients, such as fat percentage and visceral fat area.

Muscle mass

Time Frame: On admission

The muscle mass of HFpEF patients, such as thigh muscle mass

Blood uric acid

Time Frame: On admission

The blood uric acid of HFpEF patients

Study Sites (1)

Loading locations...

Similar Trials